The global doxercalciferol market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Doxercalciferol is a synthetic vitamin D2 analog used to treat secondary hyperparathyroidism in patients with chronic kidney disease with or without therapy of dialysis and also it treats metabolic bone disease. The major factor expected to drive the […]
